London-based VC firm Episode 1 Ventures has launched its third investment fund, which has £76m to deploy across early-stage B2B startups. Episode 1 Ventures first launched...
Sable Bio, a London-based B2B biotech startup, has raised £1.5m in a pre-seed funding round for its drug safety testing technology. Founded in 2023, Sable Bio...